WebThe wholly human monoclonal antibody Adecatumumab is dose- and target-dependent in metastatic breast cancer patients expressing EpCAM. The chimeric antibody, Catumaxomab, has been approved for the treatment of malignant ascites; however, this Mab showed considerable results in intrapleural administration in cancer patients. Anti … Webmc.manuscriptcentral.com

Expert Opinion on Therapeutic Targets Taylor & Francis Online

http://www.scizj.com/sci/14188.html#:~:text=ISSN%3A%201568-0096.Current%20Cancer%20Drug%20Targets%20aims%20to%20cover,cancer%20e.g.%20disease%20specific%20proteins%2C%20receptors%2C%20enzymes%2C%20genes. WebThe Manuscript Processing System (MPS) is a web-based manuscript submission and tracking system developed by Bentham Science Publishers for efficient, fast and cost effective processing of submitted manuscripts. MPS has been designed with the objective to ensure step-by-step online processing and tracking of manuscripts for authors, editors … godfrey phillips india limited head office

Nature Reviews Drug Discovery

WebApr 3, 2024 · Clinical utility of T cell engagers (TCEs) in cancer immunotherapy for solid tumors is hampered by on-target off-tumor activity and dose-limiting adverse events. WebDec 2, 2010 · Galectins are glycan-binding proteins with broad roles in physiological and pathological processes. Here, Rabinovich and colleagues discuss the therapeutic relevance of galectins to cancer and ... WebJan 29, 2024 · It will then review current therapies that have been recently developed to target these pathways, including a review of ongoing clinical studies for targeted … godfrey phillips india products